These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11256365)

  • 21. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting genetic haemochromatosis.
    Dooley JS; Walker AP
    Practitioner; 2007 May; 251(1694):82, 84, 86 passim. PubMed ID: 17564138
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemochromatosis and the liver.
    Niederau C; Erhardt A; Häussinger D; Strohmeyer G
    J Hepatol; 1999; 30 Suppl 1():6-11. PubMed ID: 10370895
    [No Abstract]   [Full Text] [Related]  

  • 24. [The prioritisation of genetic screening with primary haemochromatosis as an example].
    de Craen AJ; van Aken MO; Westendorp RG
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1442-5. PubMed ID: 12908344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary haemochromatosis - diagnosis and management.
    Allen K
    Aust Fam Physician; 2010 Dec; 39(12):938-41. PubMed ID: 21301675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary haemochromatosis: never seen a case?
    Emery J; Rose P
    Br J Gen Pract; 2001 May; 51(466):347-8. PubMed ID: 11360695
    [No Abstract]   [Full Text] [Related]  

  • 27. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia.
    de Graaff B; Neil A; Si L; Yee KC; Sanderson K; Gurrin L; Palmer AJ
    Appl Health Econ Health Policy; 2017 Aug; 15(4):521-534. PubMed ID: 28035629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium.
    Merryweather-Clarke AT; Pointon JJ; Shearman JD; Robson KJ; Jouanolle AM; Mosser A; David V; Le Gall JY; Halsall DJ; Elsey TS; Kelly A; Cox TM; Clare M; Bomford A; Vandwalle JL; Rochette J; Borot N; Coppin H; Roth MP; Ryan E; Crowe J; Totaro A; Gasparini P; Roetto A; Walker AP
    Nat Genet; 1999 Nov; 23(3):271. PubMed ID: 10545942
    [No Abstract]   [Full Text] [Related]  

  • 30. Early detection of genetic hemochromatosis: should all young adults be offered the genetic test?
    Worwood M
    Genet Test; 2000; 4(2):219-28. PubMed ID: 10953963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Should one screen systematically for genetic haemochromatosis?].
    Le Gall JY
    Presse Med; 2003 Oct; 32(34):1588-90. PubMed ID: 14576578
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis.
    Powell LW; Dixon JL; Hewett DG
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):221-34. PubMed ID: 15737886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemochromatosis].
    Moirand R
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B68-78. PubMed ID: 10891767
    [No Abstract]   [Full Text] [Related]  

  • 34. A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations.
    Cooper K; Bryant J; Picot J; Clegg A; Roderick PR; Rosenberg WM; Patch C
    QJM; 2008 Aug; 101(8):631-41. PubMed ID: 18522976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study.
    de Graaff B; Neil A; Sanderson K; Yee KC; Palmer AJ
    Aust Health Rev; 2017 Jul; 41(3):254-267. PubMed ID: 27444148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic screening for iron overload: No evidence of discrimination at 1 year.
    Hall MA; Barton JC; Adams PC; McLaren CE; Reiss JA; Castro O; Ruggiero A; Acton RT; Power TE; Bent TC
    J Fam Pract; 2007 Oct; 56(10):829-34. PubMed ID: 17908514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of screening for hemochromatosis.
    Dubois S; Kowdley KV
    Arch Intern Med; 2003 Nov; 163(20):2424-6; author reply 2426. PubMed ID: 14609776
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hereditary hemochromatosis HFE: regulatory and economic aspects of diagnosis and medical management].
    Ropert-Bouchet M; Fajardy I; Michel H
    Ann Biol Clin (Paris); 2012; 70(4):405-11. PubMed ID: 22796612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family screening for genetic haemochromatosis. What is the most effective method of contact?
    Clayton C; Hall P; Mackinnon M
    Med J Aust; 1993 Nov; 159(9):614-5. PubMed ID: 8232038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.